Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs)

被引:20
作者
Sotgia, Federica [1 ]
Fiorillo, Marco [1 ,2 ]
Lisanti, Michael P. [1 ]
机构
[1] Univ Salford, BRC, Sch Environm & Life Sci, Translat Med, Manchester M5 4WT, England
[2] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Cosenza, Italy
来源
AGING-US | 2019年 / 11卷 / 03期
关键词
cancer cell of origin; cancer stem cells (CSCs); senescence; metabolism; anti-oxidant response; tamoxifen resistance; CLONAL EVOLUTION; HETEROGENEITY; SUBPOPULATION; GENES;
D O I
10.18632/aging.101822
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Here, we discuss the expected hallmark(s) of the cancer cell of origin and how this may be related to a new tumor cell phenotype, namely "energetic" cancer stem cells (e-CSCs). e-CSCs show many features that would be characteristic of the cancer cell of origin, including the over-expression of p21-WAF (CDKN1A), a key marker of senescence. It is tempting to speculate that the cancer cell of origin and e-CSCs are closely related entities. e-CSCs possess a hybrid phenotype, sharing key hallmarks of senescence, "stemness" and cancer. e-CSCs are hyper-proliferative and have elevated mitochondrial metabolism, with an NRF2-mediated anti-oxidant response signature, including glutaredoxin (GLRX) and ALDH3A1 over-expression, possibly related to their escape from senescence. Finally, in e-CSCs, BCAS1 (Breast carcinoma-amplified sequence-1) protein expression was up-regulated by >100-fold. BCAS1 is a candidate oncogene associated with "stemness" and aggressive oncogenic behavior, such as Tamoxifen resistance.
引用
收藏
页码:1065 / 1068
页数:4
相关论文
共 21 条
[1]  
Becker M, 2005, MOL CANCER THER, V4, P151
[2]   NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness" [J].
Bonuccelli, Gloria ;
De Francesco, Ernestina Marianna ;
de Boer, Rianne ;
Tanowitz, Herbert B. ;
Lisanti, Michael P. .
ONCOTARGET, 2017, 8 (13) :20667-20678
[3]   Positional cloning of ZNF217 and NABC1:: Genes amplified at 20q13.2 and overexpressed in breast carcinoma [J].
Collins, C ;
Rommens, JM ;
Kowbel, D ;
Godfrey, T ;
Tanner, M ;
Hwang, S ;
Polikoff, D ;
Nonet, G ;
Cochran, J ;
Myambo, K ;
Jay, KE ;
Froula, J ;
Cloutier, T ;
Kuo, WL ;
Yaswen, P ;
Dairkee, S ;
Giovanola, J ;
Hutchinson, GB ;
Isola, J ;
Kallioniemi, OP ;
Palazzolo, M ;
Martin, C ;
Ericsson, C ;
Pinkel, D ;
Albertson, D ;
Li, WB ;
Gray, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8703-8708
[4]   BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions [J].
Fard, Maryam K. ;
van der Meer, Franziska ;
Sanchez, Paula ;
Cantuti-Castelvetri, Ludovico ;
Mandad, Sunit ;
Jaekel, Sarah ;
Fornasiero, Eugenio F. ;
Schmitt, Sebastian ;
Ehrlich, Marc ;
Starost, Laura ;
Kuhlmann, Tanja ;
Sergiou, Christina ;
Schultz, Verena ;
Wrzos, Claudia ;
Brueck, Wolfgang ;
Urlaub, Henning ;
Dimou, Leda ;
Stadelmann, Christine ;
Simons, Mikael .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (419)
[5]   High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant [J].
Farnie, Gillian ;
Sotgia, Federica ;
Lisanti, Michael P. .
ONCOTARGET, 2015, 6 (31) :30472-30486
[6]   "Energetic" Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy [J].
Fiorillo, Marco ;
Sotgia, Federica ;
Lisanti, Michael P. .
FRONTIERS IN ONCOLOGY, 2019, 8
[7]   Mitochondrial "power" drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer [J].
Fiorillo, Marco ;
Sotgia, Federica ;
Sisci, Diego ;
Cappello, Anna Rita ;
Lisanti, Michael P. .
ONCOTARGET, 2017, 8 (12) :20309-20327
[8]   Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging [J].
Gomes, Ana P. ;
Price, Nathan L. ;
Ling, Alvin J. Y. ;
Moslehi, Javid J. ;
Montgomery, Magdalene K. ;
Rajman, Luis ;
White, James P. ;
Teodoro, Joao S. ;
Wrann, Christiane D. ;
Hubbard, Basil P. ;
Mercken, Evi M. ;
Palmeira, Carlos M. ;
de Cabo, Rafael ;
Rolo, Anabela P. ;
Turner, Nigel ;
Bell, Eric L. ;
Sinclair, David A. .
CELL, 2013, 155 (07) :1624-1638
[9]   Clonal evolution in cancer [J].
Greaves, Mel ;
Maley, Carlo C. .
NATURE, 2012, 481 (7381) :306-313
[10]   Aldehyde dehydrogenase is used by cancer cells for energy metabolism [J].
Kang, Joon Hee ;
Lee, Seon-Hyeong ;
Hong, Dongwan ;
Lee, Jae-Seon ;
Ahn, Hee-Sung ;
Ahn, Ju-Hyun ;
Seong, Tae Wha ;
Lee, Chang-Hun ;
Jang, Hyonchol ;
Hong, Kyeong Man ;
Lee, Cheolju ;
Lee, Jae-Ho ;
Kim, Soo-Youl .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2016, 48 :e272-e272